Mouse CXCL13/BLC/BCA-1 Antibody Summary
Ile22-Ala109
Accession # O55038
Applications
Mouse CXCL13/BLC/BCA-1 Sandwich Immunoassay
Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.
Scientific Data
Chemotaxis Induced by CXCL13/BLC/BCA‑1 and Neutralization by Mouse CXCL13/BLC/BCA‑1 Antibody. Recombinant Mouse CXCL13/BLC/BCA-1 (Catalog # 470-BC) chemoattracts the BaF3 mouse pro-B cell line transfected with human CXCR5 in a dose-dependent manner (orange line). The amount of cells that migrated through to the lower chemotaxis chamber was measured by Resazurin (Catalog # AR002). Chemotaxis elicited by Recombinant Mouse CXCL13/BLC/BCA-1 (4 µg/mL) is neutralized (green line) by increasing concentrations of Rat Anti-Mouse CXCL13/BLC/BCA-1 Monoclonal Antibody (Catalog # MAB470). The ND50 is typically 12-30 µg/mL.
Reconstitution Calculator
Preparation and Storage
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Background: CXCL13/BLC/BCA-1
CXCL13, also known as B-lymphocyte chemoattractant (BLC) and BCA-1, is a CXC chemokine that is constitutively expressed in secondary lymphoid organs. Mouse CXCL13 cDNA encodes a precursor protein of 109 amino acid residues with a putative leader sequence of 21 residues. Mature mouse CXCL13 shares 64% amino acid sequence similarity with the human protein and 23-34% amino acid sequence identity with other known CXC chemokines. Recombinant or chemically synthesized CXCL13 is a potent chemoattractant for B lymphocytes but not T lymphocytes, monocytes or neutrophils. BLR1, a G protein-coupled receptor originally isolated from Burkitt’s lymphoma cells, has now been shown to be the specific receptor for CXCL13. Among cells of the hematopoietic lineages, the expression of BLR1, now designated CXCR5, is restricted to B lymphocytes and a subpopulation of T helper memory cells. Mice lacking BLR1 have been shown to lack inguinal lymph nodes. These mice were also found to have impaired development of Peyer’s patches and defective formation of primary follicles and germinal centers in the spleen as a result of the inability of B lymphocytes to migrate into B cell areas.
- Gunn, M.D. et al. (1998) Nature, 391:799.
- Legler, D.F. et al. (1998) J. Exp. Med. 187:655.
- Forster, R. et al. (1996) Cell 87:1037.
Product Datasheets
Citations for Mouse CXCL13/BLC/BCA-1 Antibody
R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.
13
Citations: Showing 1 - 10
Filter your results:
Filter by:
-
Antibodies against endogenous retroviruses promote lung cancer immunotherapy
Authors: KW Ng, J Boumelha, KSS Enfield, J Almagro, H Cha, O Pich, T Karasaki, DA Moore, R Salgado, M Sivakumar, G Young, M Molina-Arc, S de Carné T, P Anastasiou, A Fendler, L Au, STC Shepherd, C Martínez-R, C Puttick, JRM Black, TBK Watkins, H Kim, S Shim, N Faulkner, J Attig, S Veeriah, N Magno, S Ward, AM Frankell, M Al Bakir, EL Lim, MS Hill, GA Wilson, DE Cook, NJ Birkbak, A Behrens, N Yousaf, S Popat, A Hackshaw, TRACERx Co, CAPTURE Co, CT Hiley, K Litchfield, N McGranahan, M Jamal-Hanj, J Larkin, SH Lee, S Turajlic, C Swanton, J Downward, G Kassiotis
Nature, 2023-04-12;616(7957):563-573.
Species: Mouse
Sample Types: In Vivo
Applications: Neutralization -
B Cells Are Required to Generate Optimal Anti-Melanoma Immunity in Response to Checkpoint Blockade
Authors: Shubhra Singh, Jason Roszik, Neeraj Saini, Vipul Kumar Singh, Karishma Bavisi, Zhiqiang Wang et al.
Frontiers in Immunology
-
TGF-?-mediated silencing of genomic organizer SATB1 promotes Tfh cell differentiation and formation of intra-tumoral tertiary lymphoid structures
Authors: Chaurio RA, Anadon CM, Lee Costich T et al.
Immunity
-
CXCL13 Is an Indicator of Germinal Center Activity and Alloantibody Formation Following Transplantation
Authors: Emma S. Crichton, Shan Zeng, G. Michael La Muraglia, I. Raul Badell
Transplantation Direct
-
CXCL13 antibody for the treatment of autoimmune disorders.
Authors: Klimatcheva E, Pandina T, Reilly C, Torno S, Bussler H, Scrivens M, Jonason A, Mallow C, Doherty M, Paris M, Smith E, Zauderer M
BMC Immunol, 2015-02-12;16(0):6.
Species: Mouse
Sample Types: Recombinant Protein
Applications: Direct ELISA -
M2b macrophage elimination and improved resistance of mice with chronic alcohol consumption to opportunistic infections.
Authors: Ohama H, Asai A, Ito I, Suzuki S, Kobayashi M, Higuchi K, Suzuki F
Am J Pathol, 2014-12-06;185(2):420-31.
Species: Mouse
Sample Types: Whole Cells
Applications: Cell Selection -
CXCL13 is elevated in Sjogren's syndrome in mice and humans and is implicated in disease pathogenesis.
Authors: Kramer J, Klimatcheva E, Rothstein T
J Leukoc Biol, 2013-07-31;94(5):1079-89.
Species: Mouse
Sample Types: Whole Cells
Applications: Neutralization -
Impaired humoral immunity and tolerance in K14-VEGFR-3-Ig mice that lack dermal lymphatic drainage.
J. Immunol., 2012-07-27;189(5):2181-90.
Species: Mouse
Sample Types: Whole Tissue
Applications: IHC-Fr -
Regulation of T(H)2 development by CXCR5+ dendritic cells and lymphotoxin-expressing B cells.
Authors: Leon B, Ballesteros-Tato A, Browning JL, Dunn R, Randall TD, Lund FE
Nat. Immunol., 2012-05-27;13(7):681-90.
Species: Mouse
Sample Types: In Vivo
Applications: Neutralization -
Response patterns of cytokines/chemokines in two murine strains after irradiation.
Authors: Zhang M, Yin L, Zhang K, Sun W, Yang S, Zhang B, Salzman P, Wang W, Liu C, Vidyasagar S, Zhang L, Ju S, Okunieff P, Zhang L
Cytokine, 2012-01-25;58(2):169-77.
Species: Mouse
Sample Types: Plasma
Applications: Luminex Development -
Unique requirements for reactivation of virus-specific memory B lymphocytes.
Authors: Weisel FJ, Appelt UK, Schneider AM, Horlitz JU, Van Rooijen N, Korner H, Mach M, Winkler TH
J. Immunol., 2010-08-25;185(7):4011-21.
Species: Mouse
Sample Types: In Vivo
Applications: Neutralization -
CXCL13 Blockade Disrupts B Lymphocyte Organization in Tertiary Lymphoid Structures without Altering B Cell Receptor Bias or Preventing Diabetes in Nonobese Diabetic Mice
Authors: Rachel A. Henry, Peggy L. Kendall
The Journal of Immunology
-
ZNF382 controls mouse neuropathic pain via silencer-based epigenetic inhibition of Cxcl13 in DRG neurons
Authors: Ma L, Yu L, Jiang BC Et al.
The Journal of experimental medicine
FAQs
No product specific FAQs exist for this product, however you may
View all Antibody FAQsReviews for Mouse CXCL13/BLC/BCA-1 Antibody
There are currently no reviews for this product. Be the first to review Mouse CXCL13/BLC/BCA-1 Antibody and earn rewards!
Have you used Mouse CXCL13/BLC/BCA-1 Antibody?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image